Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.

ABSTRACT:

SUBMITTER: Blixt L 

PROVIDER: S-EPMC9512527 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature